Guardian Pharmacy Services (GRDN) Competitors $20.93 -0.07 (-0.33%) (As of 11/15/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends GRDN vs. PETS, YI, CJJD, CVS, WBA, ACLX, KRYS, ADMA, SEM, and LTHShould you be buying Guardian Pharmacy Services stock or one of its competitors? The main competitors of Guardian Pharmacy Services include PetMed Express (PETS), 111 (YI), China Jo-Jo Drugstores (CJJD), CVS Health (CVS), Walgreens Boots Alliance (WBA), Arcellx (ACLX), Krystal Biotech (KRYS), ADMA Biologics (ADMA), Select Medical (SEM), and Life Time Group (LTH). Guardian Pharmacy Services vs. PetMed Express 111 China Jo-Jo Drugstores CVS Health Walgreens Boots Alliance Arcellx Krystal Biotech ADMA Biologics Select Medical Life Time Group PetMed Express (NASDAQ:PETS) and Guardian Pharmacy Services (NYSE:GRDN) are both small-cap retail/wholesale companies, but which is the superior investment? We will contrast the two businesses based on the strength of their community ranking, earnings, profitability, analyst recommendations, valuation, institutional ownership, media sentiment, dividends and risk. Does the MarketBeat Community favor PETS or GRDN? PetMed Express received 211 more outperform votes than Guardian Pharmacy Services when rated by MarketBeat users. However, 100.00% of users gave Guardian Pharmacy Services an outperform vote while only 45.17% of users gave PetMed Express an outperform vote. CompanyUnderperformOutperformPetMed ExpressOutperform Votes21545.17% Underperform Votes26154.83% Guardian Pharmacy ServicesOutperform Votes4100.00% Underperform VotesNo Votes Is PETS or GRDN more profitable? Guardian Pharmacy Services has a net margin of 0.00% compared to PetMed Express' net margin of -0.37%. Guardian Pharmacy Services' return on equity of 0.00% beat PetMed Express' return on equity.Company Net Margins Return on Equity Return on Assets PetMed Express-0.37% -1.00% -0.60% Guardian Pharmacy Services N/A N/A N/A Do analysts rate PETS or GRDN? PetMed Express currently has a consensus target price of $3.50, indicating a potential downside of 25.53%. Guardian Pharmacy Services has a consensus target price of $22.00, indicating a potential upside of 5.11%. Given Guardian Pharmacy Services' stronger consensus rating and higher possible upside, analysts clearly believe Guardian Pharmacy Services is more favorable than PetMed Express.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score PetMed Express 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50Guardian Pharmacy Services 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has preferable earnings and valuation, PETS or GRDN? Guardian Pharmacy Services has lower revenue, but higher earnings than PetMed Express. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPetMed Express$281.06M0.35-$7.46M-$0.06-78.33Guardian Pharmacy ServicesN/AN/AN/AN/AN/A Do institutionals & insiders believe in PETS or GRDN? 73.3% of PetMed Express shares are held by institutional investors. 1.1% of PetMed Express shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Does the media favor PETS or GRDN? In the previous week, Guardian Pharmacy Services had 7 more articles in the media than PetMed Express. MarketBeat recorded 9 mentions for Guardian Pharmacy Services and 2 mentions for PetMed Express. PetMed Express' average media sentiment score of 0.72 beat Guardian Pharmacy Services' score of -0.07 indicating that PetMed Express is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment PetMed Express 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Guardian Pharmacy Services 0 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryGuardian Pharmacy Services beats PetMed Express on 8 of the 13 factors compared between the two stocks. Ad WealthPressHow one pattern has averaged an 85% return per year since the pandemic. Over the last 5 years Roger Scott has done some pretty incredible things… He’s found hundreds of winning opportunities… He’s created some incredible strategies… And he’s even designed some amazing tools… But there is one thing he’s always kept close to the chest… And in this case, it’s been a very particular stock market pattern…. A pattern he calls the World's Most Predictable Pattern…Follow this link here and enter your email address to sign up… Get Guardian Pharmacy Services News Delivered to You Automatically Sign up to receive the latest news and ratings for GRDN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GRDN vs. The Competition Export to ExcelMetricGuardian Pharmacy ServicesDrug stores & proprietary stores IndustryMedical SectorNYSE ExchangeMarket Cap$1.30B$8.42B$5.15B$19.84BDividend YieldN/A8.40%5.18%3.51%P/E RatioN/A1.5065.5935.07Price / SalesN/A0.191,278.7517.75Price / CashN/A70.6939.7021.33Price / BookN/A0.756.474.64Net IncomeN/A-$46.88M$119.73M$982.94M7 Day Performance-2.24%-5.50%-5.13%-2.12%1 Month Performance20.43%0.71%-2.71%-0.39%1 Year PerformanceN/A-47.83%31.08%23.34% Guardian Pharmacy Services Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GRDNGuardian Pharmacy Services0.6046 of 5 stars$20.93-0.3%$22.00+5.1%N/A$1.30BN/A0.003,200Earnings ReportAnalyst ForecastNews CoveragePETSPetMed Express0.6096 of 5 stars$5.17-4.6%N/A-38.2%$106.83M$259.34M-86.17287Analyst UpgradeYI1111.1439 of 5 stars$0.66-1.5%N/A-70.7%$56.25M$2.11B-1.221,520Short Interest ↓Positive NewsGap UpCJJDChina Jo-Jo DrugstoresN/A$2.11+1.9%N/A-48.1%$14.01M$154.54M0.00980Analyst ForecastShort Interest ↑News CoverageCVSCVS Health4.9993 of 5 stars$54.04-3.2%N/A-22.1%$68.00B$368.91B13.72300,000Analyst DowngradeShort Interest ↑WBAWalgreens Boots Alliance4.2268 of 5 stars$9.01-4.0%N/A-59.1%$7.79B$147.66B-0.90312,000ACLXArcellx2.8644 of 5 stars$100.48-5.7%N/A+68.4%$5.40B$110.32M-141.52130Analyst ForecastInsider SellingShort Interest ↓KRYSKrystal Biotech4.7252 of 5 stars$187.22-4.4%N/A+73.6%$5.38B$50.70M105.77229ADMAADMA Biologics3.6392 of 5 stars$21.78-3.1%N/A+399.7%$5.08B$258.21M77.79530Gap UpSEMSelect Medical4.4035 of 5 stars$39.18-2.5%N/A+62.1%$5.07B$6.97B18.3154,600Analyst UpgradeAnalyst RevisionLTHLife Time Group4.0788 of 5 stars$24.18-2.6%N/A+64.3%$5.00B$2.52B35.0437,000Positive NewsGap DownHigh Trading Volume Related Companies and Tools Related Companies PetMed Express Alternatives 111 Alternatives China Jo-Jo Drugstores Alternatives CVS Health Alternatives Walgreens Boots Alliance Alternatives Arcellx Alternatives Krystal Biotech Alternatives ADMA Biologics Alternatives Select Medical Alternatives Life Time Group Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:GRDN) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Guardian Pharmacy Services, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Guardian Pharmacy Services With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GRDN Stock Alerts